Ulf Bladin

Vorstandsvorsitzender bei PROT DIAG

62 Jahre

Health Technology

Consumer Services

Finance

Profil

Ulf Bladin currently works at Prolight Diagnostics AB, as Chief Executive Officer & Director, TEQCool AB, as Chairman, SPCIN AB, as Director, UB Management Invest AB, as Director, and Rewell Medical AB, as Partner.
Mr. Bladin also formerly worked at DentoSystem Scandinavia AB, as Chief Executive Officer, Pfizer Inc., as Marketing Director, SpectraCure AB, as Independent Director, Lumito AB, as Independent Director, Cardeon AB (Old), as Director, Cardeon AB, as Director, HYCOR Biomedical, Inc., as Vice President-EMEA Region & General Manager from 2016 to 2018, Merck & Co., Inc., as Principal, Phadia AB, as Vice President-Marketing & Health Economy from 2010 to 2011, and Thermo Fisher Scientific, Inc., as VP-Europe Commercial Operations.
Mr. Bladin received his undergraduate degree from Karolinska Institutet and undergraduate degree and graduate degree from Stockholm School of Economics.

Aktive Positionen von Ulf Bladin

Unternehmen	Position	Beginn
PROT DIAG	Vorstandsvorsitzender	01.07.2020
TEQCool AB TEQCool AB TEQCool AB is a Swedish medical technology company specializing in a patented, non-invasive brain cooling therapy that rapidly and precisely reduces brain temperature via the nasal cavity ’ s natural heat exchange system. The company is based in Lund, Sweden. The company’s approach uses balloon catheters placed intranasally to lower brain temperature by approximately 2ºC within one hour, enabling fast, targeted, and safe temperature management without surgery or deep sedation. This therapy is intended to reduce brain metabolism, oxygen demand, and fever in neurocritical care patients, aiming to prevent secondary brain injury and support neurological recovery. TEQCool’s technology is designed for patients with severe brain injuries and neurogenic fever in conditions such as traumatic brain injury, subarachnoid hemorrhage, status epilepticus, stroke, acute encephalopathy, neonatal hypoxic-ischemic encephalopathy, cardiac arrest, and migraine. The system includes a single-use nasal cooling kit and an adjustable cooling device that allows clinicians to personalize treatment with real-time temperature monitoring. The CEO of the company is Johan Ingemansson.	Vorsitzender	-
UB Management Invest AB	Direktor/Vorstandsmitglied	-
SPCIN AB	Direktor/Vorstandsmitglied	-
Rewell Medical AB	Corporate Officer/Principal	01.01.2019

Alle aktiven Positionen von Ulf Bladin

Ehemalige bekannte Positionen von Ulf Bladin

Unternehmen	Position	Ende
CARDEON AB	Direktor/Vorstandsmitglied	01.01.2023
HYCOR Biomedical, Inc. HYCOR Biomedical, Inc. Medical SpecialtiesHealth Technology Develops and markets medical diagnostic products	Corporate Officer/Principal	01.01.2018
Phadia AB Phadia AB Chemicals: Major DiversifiedProcess Industries Manufactures chemicals, instruments and apparatus & wholesales measuring and precision instruments	Public Communications Contact	01.01.2011
THERMO FISHER SCIENTIFIC, INC.	Corporate Officer/Principal	-
░░░░░░ ░░░░	░░░░░░░░ ░ ░░░░░░░░░	-

Sehen Sie sich die Erfahrung von Ulf Bladin im Detail an

Ausbildung von Ulf Bladin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ulf Bladin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	17
HYCOR Biomedical, Inc. HYCOR Biomedical, Inc. Medical SpecialtiesHealth Technology Develops and markets medical diagnostic products	Health Technology
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stockholm School of Economics Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Phadia AB Phadia AB Chemicals: Major DiversifiedProcess Industries Manufactures chemicals, instruments and apparatus & wholesales measuring and precision instruments	Process Industries
Thermo Fisher Scientific, Inc. Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments	Health Technology
SpectraCure AB SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment	Electronic Technology
Prolight Diagnostics AB Prolight Diagnostics AB Medical SpecialtiesHealth Technology Develops biomedical devices	Health Technology
DentoSystem Scandinavia AB DentoSystem Scandinavia AB Medical/Nursing ServicesHealth Services Provides dental care services	Health Services
Lumito AB Lumito AB Medical SpecialtiesHealth Technology Develops, manufactures, and licenses imaging based on nanoparticles	Health Technology
SPCIN AB
Cardeon AB (Old) Cardeon AB (Old) Financial ConglomeratesFinance Provides investment services	Finance
Rewell Medical AB
TEQCool AB TEQCool AB TEQCool AB is a Swedish medical technology company specializing in a patented, non-invasive brain cooling therapy that rapidly and precisely reduces brain temperature via the nasal cavity ’ s natural heat exchange system. The company is based in Lund, Sweden. The company’s approach uses balloon catheters placed intranasally to lower brain temperature by approximately 2ºC within one hour, enabling fast, targeted, and safe temperature management without surgery or deep sedation. This therapy is intended to reduce brain metabolism, oxygen demand, and fever in neurocritical care patients, aiming to prevent secondary brain injury and support neurological recovery. TEQCool’s technology is designed for patients with severe brain injuries and neurogenic fever in conditions such as traumatic brain injury, subarachnoid hemorrhage, status epilepticus, stroke, acute encephalopathy, neonatal hypoxic-ischemic encephalopathy, cardiac arrest, and migraine. The system includes a single-use nasal cooling kit and an adjustable cooling device that allows clinicians to personalize treatment with real-time temperature monitoring. The CEO of the company is Johan Ingemansson.
UB Management Invest AB
Cardeon AB Cardeon AB Financial ConglomeratesFinance Provides investment services	Finance